This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market.
In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.Major Growth Drivers:Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market.
Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.Expected Revenue Growth:The global market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107Accessories to Fuel the Growth of Varicose Vein Treatment MarketHowever, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of market.
In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107This report broadly segments the Varicose Vein Treatment market into mode of treatment and products.
On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.
The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.Based on type of products, the market is segmented into ablation devices, venous closure products, and surgical products.